Former Novartis Client Well being Israel CEO Estee Rosen Joins Sativus Tech
Estee Rosen
Rosen’s appointment strengthens Saffron Tech’s place as the corporate appears to be like to speed up its progress technique and drive incomes.
Tel Aviv, Israel, Nov. 21, 2022 (GLOBE NEWSWIRE) — Sativus Tech (SATT), the one AgTech firm that has efficiently grown saffron utilizing its superior vertical farming know-how, at this time introduced it has appointed Estee Rosen because the lead for Enterprise Improvement in Wellness, Well being and Magnificence for Saffron Tech, a subsidiary of Sativus Tech. On this position, Estee will lead Saffron Tech’s go-to market method to the wellness, well being, and sweetness markets, creating key partnerships to generate revenues as a part of the corporate’s go-to-market technique.
“Estee is an excellent addition to the Saffron Tech crew, bringing a dynamic mix of management expertise to guide us as we enter the B2B market,” mentioned Tal Wilk-Glazer, CEO of Sativus Tech. “Her management expertise in efficiently creating new markets can be very important as Sativus Tech focuses on speedy progress and world enlargement. It’s a nice alternative that Estee joined the crew at this pivotal time, and we welcome her.”
Estee possesses greater than 20 years of management expertise within the healthcare trade. She beforehand served as CEO of Novartis Client Well being Israel and based health-carecompanies Blueyes and BluPharma. Her expertise within the healthcare sector will assist Saffron Tech as the corporate appears to be like to fulfill the rising demand for saffron in meals dietary supplements, cosmetics, and wellness merchandise.
Saffron is understood for its anti-anxiety, antidepressant, and antioxidant properties. Saffron Tech can produce a constant, high-grade and large-scale provide of saffron for the well being, wellness and sweetness industries.
“I’m excited to affix the Saffron Tech crew and assist set up a strong base that may appeal to new enterprise within the well being, wellness, and sweetness house,” mentioned Estee Rosen. “I imagine saffron has the potential to deliver another, pure remedy for folks with melancholy and anxiousness and I’m happy to affix this crew to deliver this imaginative and prescient to a actuality. Collectively we will disrupt the market and take the corporate to new horizons. I stay up for exploring all of the pathways that may result in world enlargement and revenues.”
About Sativus Tech Corp:
Sativus Tech Corp (OTC: SATT) is an AgTech firm that makes use of its superior vertical farming know-how to extend the manufacturing of low yield meals merchandise within the world market. The corporate focuses on the analysis, growth, and commercialization of agricultural merchandise which can be excessive in demand however scarce in provide. Dependable manufacturing of those extremely coveted meals merchandise can be utilized in numerous purposes together with pharmaceutical, nutraceutical, culinary, magnificence, well being, and wellness industries. Sativus Tech Corp’s know-how gives a accountable and sustainable option to develop crops in a world confronted with environmental challenges and dwindling earth reserves, diminishing water sources, and unstable climate situations.
Sativus Tech Corp’s subsidiary, Saffron Tech, is revolutionizing the AgTech world by creating the protocols to develop saffron in indoor vertical farms. It’s also rising the manufacturing of the spice by multiplying the variety of annual harvests. The pharmaceutical trade is now turning extra of its scientific consideration to saffron’s medicinal properties, which at the moment are being utilized in pharmaceutical and nutraceutical purposes for ADHD, anxiousness and extra.
Ahead-Trying Statements:
All statements apart from statements of historic details contained on this press launch are “forward-looking statements,” which can typically, however not all the time, be recognized by means of such phrases as “expects,” “anticipates,” “intends,” “estimates,” “plans,” “potential,” “potential,” “possible,” “believes,” “seeks,” “could,” “will,” “ought to,” “may” or the unfavourable of such phrases or different related expressions. These statements contain recognized and unknown dangers, uncertainties and different components which can trigger precise outcomes, efficiency, or achievements to vary materially from these expressed or implied by such statements. These components embrace uncertainties as to the Firm’s worldwide manufacturing and provide chain, market acceptance of the Firm’s sensible baggage, efficiently implementing the Firm’s progress technique, dependence on key Firm personnel, modifications in financial situations, competitors and different dangers together with, however not restricted to, these described from within the Firm’s Annual Report on Type 10-Ok, filed with the Securities and Alternate Fee on April 11, 2022 (the “SEC”), and different filings and submissions with the SEC. These forward-looking statements communicate solely as of the date hereof and the Firm disclaims any obligations to replace these statements besides as could also be required by legislation. The Firm intends that every one forward-looking statements be topic to the safe-harbor provisions of the Personal Securities Litigation Reform Act of 1995.
Investor Relations Contact:
Tal Wilk Glazer
Chief Government Officer
info@saffron.ag
800-608-6432
Attachment
Source link